Davide Carlei

istituto superiore di sanita (iss)

H指数:13

被引数:1,020

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial

CLINICAL CANCER RESEARCH

IF10.2

2019-09-0333

OAAI

Cox, M. Christina; Castiello, Luciano; Mattei, Mauro; Santodonato, Laura; D'Agostino, Giuseppina; Muraro, Elena; Martorelli, Debora; Lapenta, Caterina; Di Napoli, Arianna; Di Landro, Francesca; Cangemi, Michela; Pavan, Antonio; Castaldo, Paolo; Hohaus, Stefan; Donati, Simona; Montefiore, Enrica; Berdini, Cinzia; Carlei, Davide; Monque, Domenica M.; Ruco, Luigi; Prosperi, Daniela; Tafuri, Agostino; Spadaro, Francesca; Sestili, Paola; Spada, Massimo; Dolcetti, Riccardo; Santini, Stefano M.; Rozera, Carmela; Arico, Eleonora; Capone, Imerio; Belardelli, Filippo

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

达卡巴嗪激活抗肿瘤免疫后肿瘤内注射ifn-α 树突状细胞: 晚期黑色素瘤I期试验的结果

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2015-05-0237

OAAI

Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2010-10-2744

OAAI

A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice